Cognizant Technology 'A'

Cognizant shares fell 2.2% in premarket trading after the release of Q2 results. Analysts had previously raised concerns about rising employee turnover, weakening utilization and pressure in the health-sciences segment, which accounts for around 30% of revenue. Several firms subsequently cut their price targets sharply (average reduction about 31%), and the company shows a negative Earnings ESP of -1.34%. After a recent rally driven by a new AI unit and a partnership with Anthropic, profit-taking and uncertainty about a possible guidance adjustment led to the setback. » More on de.investing.com

Cognizant announced a dedicated EMEA AI unit designed to deliver scaled, production-ready AI solutions across three service tiers (Foundation, Accelerate, Transform). Earlier, Cognizant became a Global Premier Partner in Anthropic’s Claude Partner Network and signed a five-year technology and AI partnership with The Andover Companies. The stock rose notably ahead of expected Q2 results due tomorrow; analysts see expected EPS of $1.38 and revenue of about $5.48 billion, after the company beat EPS estimates in each of the last four quarters. » More on de.investing.com

Cognizant and The Andover Companies have entered a five-year partnership to modernize the policy administration platform, build an enterprise-wide, AWS-native data platform based on the Medallion architecture, and strengthen security and compliance, including support for NYDFS requirements. Cognizant will provide application and managed services, API and platform upgrades, as well as workflow and product optimizations. AI use cases will also be evaluated and prototypes developed on the Neuro AI platform to address underwriting, claims handling and software development scenarios. » More on de.investing.com